In patients with established cardiovascular disease people who have already had a heart attack, stroke or coronary or peripheral artery disease semaglutide is now FDA-approved to reduce the risk of another heart attack or stroke or death from heart disease
These recommendations are backed by research, not just opinions from bodybuilding forums, showing how to preserve lean mass during major calorie cuts
Review the semaglutide dosage guide to understand what to expect at each dose level, and plan your dietary adjustments accordingly
Mechanism of Action: GLP-1 receptor agonists work through multiple physiological pathways: Central appetite suppression : These medications cross the blood-brain barrier and activate GLP-1 receptors in the hypothalamus and brainstem, reducing hunger signals and increasing satiety Gastric emptying delay : By slowing stomach emptying, patients experience prolonged fullness after meals Insulin secretion enhancement : Glucose-dependent insulin release improves glycemic control Glucagon suppression : Reduced glucagon secretion decreases hepatic glucose production Tirzepatide offers dual agonism at both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, potentially providing enhanced weight loss efficacy compared to single-agonist medications
semaglutide, a GLP-1 medication meant to sustain the fullness signal over time
